C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2

Immunology and Cell Biology

Volumn 91, Issue 10, 2013, Pages 625-633

  Croker, Daniel E ^a   Halai, Reena ^a   Fairlie, David P ^a   Cooper, Matthew A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

BRET; C5a; inflammation; interleukin 10; macrophages

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A [DEARGININE]; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5L2 RECEPTOR; COMPLEMENT RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; MICROSCOPY; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CHO CELLS; COMPLEMENT C5A, DES-ARGININE; CRICETINAE; CRICETULUS; CYCLIC AMP; CYTOKINES; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HUMANS; MACROPHAGES; MODELS, BIOLOGICAL; MONOCYTES; PEPTIDES, CYCLIC; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; RECEPTOR, ANAPHYLATOXIN C5A; TRANSFECTION; UP-REGULATION;

EID: 84888315392     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.48     Document Type: Article

References (42)

1. Lee H, Whitfeld PL, Mackay CR. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol 2008; 86: 153-160.
2. Monk PN, Scola AM, Madala P, Fairlie DP. Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 2007; 152: 429-448.
3. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4: 133-142.
4. Marder SR, Chenoweth DE, Goldstein IM, Perez HD. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des arg. J Immunol 1985; 134: 3325-3331.
5. Ricklin D, Lambris JD. Complement-targeted therapeutics. Nat Biotechnol 2007; 25: 1265-1275.
6. Riedemann NC, Guo R-F, Ward PA. A key role of C5a/C5aR activation for the development of sepsis. J Leukoc Biol 2003; 74: 966-970.
7. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM. The role of the complement system in ischemia-reperfusion injury. Shock 2004; 21: 401-409.
8. Weissmann G. Pathogenesis of rheumatoid arthritis. J Clin Rheumatol 2004; 10: S26-S31.
9. Boulay F, Mery L, Tardif M, Brouchon L, Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 1991; 30: 2993-2999.
10. Gerard NP, Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991; 349: 614-617.
11. Ohno M, Hirata T, Enomoto M, Araki T, Ishimaru H, Takahashi TA. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol Immunol 2000; 37: 407-412.
12. Buhl AM, Avdi N, Worthen GS, Johnson GL. Mapping of the C5a receptor signal transduction network in human neutrophils. Proc Natl Acad Sci USA 1994; 91: 9190-9194.
13. Braun L, Christophe T, Boulay F. Phosphorylation of Key Serine Residues Is Required for Internalization of the Complement 5a (C5a) Anaphylatoxin Receptor via a beta-Arrestin, Dynamin, and Clathrin-dependent Pathway. J Biol Chem 2003; 278: 4277-4285.
14. Cain SA, Monk PN. The Orphan Receptor C5L2 Has High Affinity Binding Sites for Complement Fragments C5a and C5a des-Arg74. J Biol Chem 2002; 277: 7165-7169.
15. Okinaga S, Slattery D, Humbles A, Zsengeller Z, Morteau O, Kinrade MB et al. C5L2, a nonsignaling C5A binding protein. Biochemistry 2003; 42: 9406-9415.
16. Johswich K, Martin M, Thalmann J, Rheinheimer C, Monk PN, Klos A. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines. J Biol Chem 2006; 281: 39088-39095.
17. Gerard NP, Lu B, Liu P, Craig S, Fujiwara Y, Okinaga S et al. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J Biol Chem 2005; 280: 39677-39680.
18. Scola A-M, Johswich K-O, Morgan BP, Klos A, Monk PN. The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol Immunol 2009; 46: 1149-1162.
19. Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, Lim YS et al. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem2009; 285: 7633-7644.
20. Vischer HF, Watts AO, Nijmeijer S, Leurs R. G protein-coupled receptors: walking handin- hand, talking hand-in-hand? Br J Pharmacol 2011; 163: 246-260.
21. Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, Brabet I et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat Chem Biol 2010; 6: 587-594.
22. Ferré S, Baler R, Bouvier M, Caron MG, Devi LA, Fuxe TDK et al. Building a new conceptual framework for receptor heteromers. Nat Chem Biol 2009; 5: 131-134.
23. Lohse MJ, Nikolaev VO, Hein P, Hoffmann C, Vilardaga J-P, Bünemann M. Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. Trends Pharmacol Sci 2008; 29: 159-165.
24. Pfleger KDG, Eidne KA. Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells. Biochem J 2005; 385: 625-637.
25. Floyd DH, Geva A, Bruinsma SP, Overton MC, Blumer KJ, Baranski TJ. C5a Receptor Oligomerization: II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast. J Biol Chem 2003; 278: 35354-35361.
26. Huttenrauch F, Pollok-Kopp B, Oppermann MG. Protein-coupled receptor kinases promote phosphorylation and beta-Arrestin-mediated internalization of CCR5 Homoand Hetero-oligomers. J Biol Chem 2005; 280: 37503-37515.
27. Halai R, Croker DE, Suen JY, Fairlie DP, Cooper MA. A Comparative study of impedance versus optical label-free systems relative to labelled assays in a predominantly G coupled GPCR (C5aR) signalling. Biosensors 2012; 2: 273-290.
28. Reis ES, Chen H, Sfyroera G, Monk PN, Kohl J, Ricklin D et al. C5a receptor-dependent cell activation by physiological concentrations of desarginated c5a: insights from a novel label-free cellular assay. J Immunol 2012; 189: 4797-4805.
29. Finch AM, Wong AK, Paczkowski NJ, Wadi SK, Craik DJ, Fairlie DP et al. Lowmolecular- weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J Med Chem 1999; 42: 1965-1974.
30. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang M, Mackay CR et al. Functional roles for C5a receptors in sepsis. Nature Med 2008; 14: 551-557.
31. Zhang X, Schmudde I, Laumonnier Y, Pandey MK, Clark JR, Konig P et al. A critical role for C5L2 in the Pathogenesis of experimental allergic asthma. J Immunol 2010; 185: 6741-6752.
32. Fisette A, Munkonda MN, Oikonomopoulou K, Paglialunga S, Lambris JD, Cianflone K. C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice. Immunobiology 2013; 218: 127-133.
33. Lim J, Iyer A, Suen JY, Seow V, Reid RC, Brown L et al. C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J 2013; 27: 822-831.
34. Yan C, Gao H. New insights for C5a and C5a receptors in sepsis. Front Immunol 2012; 3: 368.
35. Bosmann M, Haggadone MD, Zetoune FS, Sarma JV, Ward PA. The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation. Eur J Immunol 2013; 43: 1907-1913.
36. Chen N-J, Mirtsos C, Suh D, Lu Y-C, Lin W-J, McKerlie C et al. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 2007; 446: 203-207.
37. Gao H, Neff TA, Guo R-F, Speyer CL, Sarma JV, Tomlins S et al. Evidence for a functional role of the second C5a receptor C5L2. FASEB J 2005; 19: 1003-1005.
38. Konteatis ZD, Siciliano SJ, Riper GV, Molineaux CJ, Pandya S, Fischer P et al. Development of C5a receptor antagonists: differential loss of functional responses. J Immunol 1994; 153: 4200-4205.
39. Verreck FAW. Human IL-23-producing type 1 macrophages promote but IL-10- producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101: 4560-4565.
40. Pfleger KD, Dromey JR, Dalrymple MB, Lim EM, Thomas WG, Eidne KA. Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged proteinprotein interactions in live cells. Cell Signal 2006; 18: 1664-1670.
41. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 2012; 9: 676-682.
42. Jaskolski F, Mulle C, Manzoni OJ. An automated method to quantify and visualize colocalized fluorescent signals. J Neurosci Methods 2005; 146: 42-49.